- Home
- Paclitax 100 mg Injection 16.7 ml
Paclitax 100 mg Injection 16.7 ml Substitute
Paclitax 100 mg Injection 16.7 ml Substitute
Verified Ingredients and Effects
Composition:
PACLITAXEL-100MG
Uses:
Paclitax 100 mg Injection 16.7 ml is used in the treatment of ovarian cancer, breast cancer, and non-small cell lung cancer. The detailed uses of Paclitax 100 mg Injection 16.7 ml are as follows:<br/>• Treating Ovarian Cancer: Paclitax 100 mg Injection 16.7 ml helps to treat ovarian cancer by inhibiting cancer cell growth and proliferation.<br/>• Managing Breast Cancer: Paclitax 100 mg Injection 16.7 ml is used to manage breast cancer, particularly in patients with metastatic disease, slowing disease progression and improving symptoms.<br/>• Treating Non-Small Cell Lung Cancer (NSCLC): Paclitax 100 mg Injection 16.7 ml treats NSCLC by interfering with cell division, inhibiting tumor growth, and slowing disease progression.<br/>• Reducing Tumor Growth in AIDS-Related Kaposi's Sarcoma: Paclitax 100 mg Injection 16.7 ml also helps to manage Kaposi's sarcoma in patients with AIDS by reducing tumor growth and alleviating symptoms.<br/>
Medicinal Benefits:
Paclitax 100 mg Injection 16.7 ml belongs to the group of anti-cancer medicines called anti-microtubule agents used to treat various types of cancers, including ovarian and breast cancer (in advanced/spreading state or after surgery) and advanced-stage non-small cell lung cancer. It may also be used when other treatments have failed or in combination with other treatments. Paclitax 100 mg Injection 16.7 ml may also be indicated in patients with Kaposi’s sarcoma (cancer that develops from the cells that line lymph or blood vessels) associated with AIDS (Acquired Immuno-Deficiency Syndrome), where other treatments have not been effective. Paclitax 100 mg Injection 16.7 ml contains ‘Paclitaxel’, which works by preventing the growth of certain cancer cells.
FAQs
Paclitax 100 mg Injection 16.7 ml is used to treat Ovarian cancer, breast cancer, non-small cell lung cancer.
Paclitax 100 mg Injection 16.7 ml works by stopping cell division and preventing the growth of certain cancer cells.
Paclitax 100 mg Injection 16.7 ml might cause sterility which could be permanent. Please talk to your doctor if you have any concerns.
The most common side effect of Paclitax 100 mg Injection 16.7 ml is hair loss. The hair may grow back after the treatment with Paclitax 100 mg Injection 16.7 ml is finished. However, consult your doctor if you have any concerns.
Yes, Paclitax 100 mg Injection 16.7 ml is cytotoxic. It works by interfering with the growth of cancer cells, preventing them from dividing and causing them to die. However, its cytotoxic nature also means it can affect normal, healthy cells, potentially leading to side effects.
Yes, Paclitax 100 mg Injection 16.7 ml is considered a vesicant. A vesicant is a chemical substance that, if it leaks out of the vein (extravasation), can cause blistering of the skin and surrounding tissues. If Paclitax 100 mg Injection 16.7 ml accidentally leaks during intravenous (IV) infusion, it may lead to inflammation, blistering, or even tissue necrosis. Your healthcare provider will take precautions to ensure the drug is infused properly and monitor the infusion site for any signs of leakage. If extravasation occurs, the infusion should be stopped immediately, and steps should be taken to minimize the damage.
Paclitax 100 mg Injection 16.7 ml is an effective cancer treatment with a low risk of cardiac side effects. Your healthcare team will closely monitor your heart function to ensure your safety. They'll watch for any changes in heart rhythms or blood pressure, and work with you to manage any potential issues. With careful monitoring, you can receive this life-saving treatment with confidence.
Paclitax 100 mg Injection 16.7 ml is a natural product derived from the bark of the Pacific yew tree (Taxus baccata). It is a chemotherapy medication used to treat various cancers, including breast, ovarian, and lung cancer.
The common side effects of Paclitax 100 mg Injection 16.7 ml include nausea, vomiting, mild diarrhoea, and joint or muscle pain. Not everyone will experience all of these side effects, and they typically resolve once the treatment is stopped. However, if the side effects persist or worsen, please consult your doctor.